Cincinnati Financial Corp Gilead Sciences, Inc. Transaction History

Cincinnati Financial Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 06, 2020	SELL	$72.34 - $84.0 $83.8 Million - $97.3 Million	-1,158,419 Closed	0 $0
Q2 2019 Aug 07, 2019	BUY	$61.87 - $69.38 $13.6 Million - $15.3 Million	220,000 Added 23.44%	1,158,419 $78.3 Million
Q2 2017 Aug 08, 2017	BUY	N/A	938,419	938,419 $66.4 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Cincinnati Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cincinnati Financial Corp with notifications on news.